Physiomics (LON:PYC) Trading Down 13.5% – Should You Sell?

Shares of Physiomics Plc (LON:PYC) dropped 13.5% on Monday . The company traded as low as GBX 0.49 and last traded at GBX 0.52. Approximately 1,061,847 shares were traded during trading, a decline of 87% from the average daily volume of 8,003,240 shares. The stock had previously closed at GBX 0.60.

Physiomics Price Performance

The firm has a 50 day moving average of GBX 0.37 and a 200-day moving average of GBX 0.40. The stock has a market capitalization of £1.67 million, a P/E ratio of -3.24 and a beta of 1.69.

Physiomics (LON:PYC) last announced its quarterly earnings data on Monday, February 16th. The company reported GBX (0.10) EPS for the quarter. Physiomics had a negative return on equity of 127.68% and a negative net margin of 106.80%. As a group, equities analysts expect that Physiomics Plc will post -0.13 earnings per share for the current year.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.